Nexus Pharmaceuticals
Vince LoPiccolo has a strong and diverse work experience in the pharmaceutical industry. Vince started their career at Gensior/Sicor as an Account Executive, managing a nine-state territory and focusing on large acute-care hospitals and the emerging oncology market. Vince then joined Bedford Laboratories, where they held the positions of Account Executive/Trainer and Regional Sales Director, managing a region of seven Account Executives and achieving significant sales growth.
In 2014, Vince transitioned to Boehringer Ingelheim as a National Account Director, where they successfully handled the transition of GlucaGen from Bedford Laboratories to Boehringer Ingelheim and contributed to the development of marketing strategies in anticipation of generic competition.
From 2015 to 2018, Vince served as VP, GPO & Strategic Sales at Major Pharmaceuticals, where they managed national account agreements for a diverse portfolio of over 1000 SKUs and $100 million in sales, establishing strategic partnerships and implementing creative programs to bring value to GPO membership.
Currently, Vince holds the position of Vice President Sales Marketing at Nexus Pharmaceuticals, Inc., where they lead the sales and marketing team, utilizing their extensive experience in trade relations, government accounts, and directing sales activities in the East region.
Vince LoPiccolo obtained a Bachelor's degree in Marketing from Maryville University of Saint Louis. The precise years of their education are not specified.
This person is not in any offices
Nexus Pharmaceuticals
Nexus Pharmaceuticals is a US-based, family-owned, minority-owned healthcare company and proud diverse supplier. We specialize in innovative processes to make difficult-to-manufacture specialty drugs that are easier to use, less labor-intensive, and more streamlined in practice. Nexus ensures that its high-quality, FDA-approved drugs fulfill a critical, unmet medical need and delivers dependable life-saving treatment options when and where they’re needed most. We are in the process of building Project Tomorrow – a state-of-the-art manufacturing facility in Pleasant Prairie, Wisconsin and only project of its kind in the last 30 years. Read about our commitment to Wisconsin and see our progress at nexuspharma.net/project-tomorrow